Broughton takes a look at the FDA’s recent announcement that it is developing a regulatory assessment for CBD products in the U.S.
Vaping Goes Mainstream: Implementing Regulatory Testing in a Burgeoning Industry
Feb 14, 2018 | Published by Chris Allen
Photo by: R&D Magazine
Leslie Henderson, our Operations Directory at Broughton, became a co-guest writer on R&D Magazine with Darren Barrington-Light Software Marketing Specialist, Informatics & Chromatography Software at Thermo Fisher Scientific.Excerpt and full link to R&D below:
"Manufacturers in the relatively new and, up until now, unregulated electronic cigarette industry have had little need for analytical testing until recently. As vaping has become mainstream, the market for e-cigarettes has come under increased scrutiny. In May 2016, the EU implemented the updated Tobacco Products Directive (TPD), which governs the manufacturing and selling of tobacco products, to include e-cigarettes and e-liquids. In 2016 the U.S. Food and Drug Administration (FDA) also updated the Premarket Tobacco Application (PMTA) to include vaping products. These updated directives and regulations require manufacturers to register and rigorously test their products if they want to continue to market them. As regulations continue to evolve, the industry is looking to advanced instrumentation and analytical testing to comply with new quality standards."
Read the full article here.